Gotta read this amazing PR one more time: The annual report showcased diversified pharmacy revenue streams and ongoing development of the Company’s portfolio of healthcare services. The addition of 340B services and the establishment of Smart Medical Alliance is expected to yield performance benefits as well improved financial results. The report expresses a positive outlook on the financial and operational performance in 2017.
During the Earnings Call held on April 3, 2017, S. Parikh Mars (CEO), discussed avenues of expansion and advancement for the company during the coming year. The Company anticipates moving forward with efforts to upgrade its OTCMarkets listing tier from OTC Pink Current Information. The avenues include proceeding with meeting the current requirements of OTCQB or OTCQX, completing a merger or acquisition transaction to become fully SEC reporting and uplisting to a major national exchange, or a combination of both.
“I could not be prouder of all that we have accomplished in 2016,” stated S. Parikh Mars, CEO. “We released our audited financial statements for 2016 and have the utmost confidence that we can build upon our successes to achieve another year of growth and expansion in 2017. We will continue to strive to meet the expectations of our shareholders by staying transparent and forthright in the management and development of Company.”
